{"id":"W2807973130","doi":"10.1016/s2352-3018(18)30099-7","title":"What did we learn from the bictegravir switch studies?","year":2018,"lang":"en","type":"letter","venue":"The Lancet HIV","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"AIDS Vancouver","funders":"","keywords":"Tenofovir alafenamide; Emtricitabine; Dolutegravir; Medicine; Abacavir; Internal medicine; Virology; Oncology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04221756,0.001394916,0.003392109,0.001313776,0.002961187,0.008506704,0.004152395,0.05289222,0.008433524],"category_scores_gemma":[0.1467611,0.001070402,0.002111505,0.001519327,0.006975125,0.01092883,0.003279962,0.06180829,0.005530474],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006705042,"about_ca_system_score_gemma":0.007794695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005355635,"about_ca_topic_score_gemma":0.01116661,"domain_scores_codex":[0.9769472,0.01204569,0.003265794,0.002147015,0.003856002,0.001738292],"domain_scores_gemma":[0.8022684,0.1533937,0.009055862,0.004181202,0.01746278,0.01363802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003280527,0.00007357555,0.001144764,0.0007278025,0.0001898267,0.001744033,0.000466357,0.000112226,0.0002084759,0.006276548,0.9387027,0.05002559],"study_design_scores_gemma":[0.001045323,0.0003397106,0.001428004,0.002950521,0.0003497268,0.001593404,0.001160407,0.0002606045,0.0003851094,0.03922645,0.9510702,0.0001905205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0001581772,0.005327458,0.00006195908,0.98551,0.008372269,0.000005258932,0.000053607,0.00001000669,0.0005012807],"genre_scores_gemma":[0.002181871,0.005234326,0.00026441,0.9421493,0.04926426,0.00002952522,0.00003317907,0.00001791301,0.0008252393],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.05289222,"threshold_uncertainty_score":0.2232705,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07294376727259798,"score_gpt":0.3181492163741765,"score_spread":0.2452054491015785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}